This session explores the critical role of multimodal MRI imaging in preoperative evaluation and prognostic assessment of brain tumors, with particular emphasis on glioblastoma and other high-grade neoplasms. Participants will learn how advanced imaging biomarkers—including the Dark Band Sign on T2WI, diffusion-weighted imaging metrics, radiomics, and deep learning-based analysis—can predict tumor grade, molecular subtypes, and patient survival outcomes prior to surgical intervention. The session integrates traditional imaging interpretation with cutting-edge artificial intelligence frameworks to enhance differential diagnosis accuracy and inform treatment planning strategies in clinical practice.

Skill Level: Intermediate